These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1423650)

  • 1. Protein engineering of antibodies.
    Sandhu JS
    Crit Rev Biotechnol; 1992; 12(5-6):437-62. PubMed ID: 1423650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibodies: strategies for production and application.
    Morrison SL
    Annu Rev Immunol; 1992; 10():239-65. PubMed ID: 1590987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and characterization of a baculovirus-expressed mouse/human chimeric antibody against transferrin receptor.
    Shen X; Hu GB; Jiang SJ; He FR; Xing W; Li L; Yang J; Zhu HF; Lei P; Shen GX
    Protein Eng Des Sel; 2009 Dec; 22(12):723-31. PubMed ID: 19825853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered antibodies: progress and prospects.
    Wright A; Shin SU; Morrison SL
    Crit Rev Immunol; 1992; 12(3-4):125-68. PubMed ID: 1476621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
    Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
    Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetically engineered single-gene-encoded anti-TAG72 chimeric antibody secreted from myeloma cells.
    Qi Y; Xiang J
    Hum Antibodies Hybridomas; 1995; 6(4):161-6. PubMed ID: 8688499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-IL-2 fusion proteins: a novel strategy for immune protection.
    Penichet ML; Harvill ET; Morrison SL
    Hum Antibodies; 1997; 8(3):106-18. PubMed ID: 9322080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody therapeutics, antibody engineering, and the merits of protein stability.
    Demarest SJ; Glaser SM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolabeling of CD3-positive lymphocytes with a recombinant single-chain antibody/alkaline phosphatase conjugate.
    Bourin P; Servat A; Lataillade JJ; Goyffon M; Vaux D; Billiald P
    Biol Chem; 2000 Feb; 381(2):173-8. PubMed ID: 10746749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical applications of single-chain antibodies.
    Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
    Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody engineering: an overview.
    O'Kennedy R; Roben P
    Essays Biochem; 1991; 26():59-75. PubMed ID: 1778186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction and expression of single chain Fv antibody against human bladder carcinoma].
    Zhang M; Yu L; Huang H
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for cancer: construction, expression and functional characterization of chimeric antibodies.
    Motmans K; Thirion S; Heyligen H; Janssens J; Raus J; Vandevyver C
    Eur J Cancer Prev; 1996 Dec; 5(6):512-9. PubMed ID: 9061286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering antibodies for stability and efficient folding.
    Honegger A
    Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture.
    Bender E; Woof JM; Atkin JD; Barker MD; Bebbington CR; Burton DR
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):74-9. PubMed ID: 8518367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.